Litcius/Paper detail

Regulated Cell Death Pathways in Pathological Cardiac Hypertrophy

Shengnan Wu, Ding Ding, Deguo Wang

2024Reviews in Cardiovascular Medicine11 citationsDOIOpen Access PDF

Abstract

Cardiac hypertrophy is characterized by an increased volume of individual cardiomyocytes rather than an increase in their number. Myocardial hypertrophy due to pathological stimuli encountered by the heart, which reduces pressure on the ventricular walls to maintain cardiac function, is known as pathological hypertrophy. This eventually progresses to heart failure. Certain varieties of regulated cell death (RCD) pathways, including apoptosis, pyroptosis, ferroptosis, necroptosis, and autophagy, are crucial in the development of pathological cardiac hypertrophy. This review summarizes the molecular mechanisms and signaling pathways underlying these RCD pathways, focusing on their mechanism of action findings for pathological cardiac hypertrophy. It intends to provide new ideas for developing therapeutic approaches targeted at the cellular level to prevent or reverse pathological cardiac hypertrophy.

Topics & Concepts

PathologicalNecroptosisMedicineMuscle hypertrophyPyroptosisCardiac hypertrophyAutophagyHeart failureProgrammed cell deathCardiologyApoptosisInternal medicineBiologyReceptorInflammasomeBiochemistryCardiac Fibrosis and RemodelingInflammasome and immune disordersAutophagy in Disease and Therapy
Regulated Cell Death Pathways in Pathological Cardiac Hypertrophy | Litcius